Molecules/SUTIMLIMAB

SUTIMLIMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: Complement C1s inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BIVV-009BIVV009EnjaymoENJAYMOSUTIMLIMABSUTIMLIMAB JOMESUTIMLIMAB-JOMETNT-009TNT009

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SUTIMLIMAB

Loading drug network...